688
Participants
Start Date
March 4, 2021
Primary Completion Date
April 21, 2023
Study Completion Date
April 21, 2023
Entresto
There is no treatment allocation. Patients administered Entresto by prescription that have started before inclusion of the patient into the study will be enrolled.
Novartis Investigative Site, Ichinomiya
Novartis Investigative Site, Ichinomiya
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Nishio
Novartis Investigative Site, Ōbu
Novartis Investigative Site, Yatomi
Novartis Investigative Site, Funabashi
Novartis Investigative Site, Kashiwa
Novartis Investigative Site, Sakura
Novartis Investigative Site, Yachiyo
Novartis Investigative Site, Imabari
Novartis Investigative Site, Matsuyama
Novartis Investigative Site, Chikushino-shi
Novartis Investigative Site, Kasuya-gun
Novartis Investigative Site, Ukiha
Novartis Investigative Site, Iwaki
Novartis Investigative Site, Maebashi
Novartis Investigative Site, Takasaki
Novartis Investigative Site, Fuchū
Novartis Investigative Site, Mihara
Novartis Investigative Site, Takehara
Novartis Investigative Site, Takehara
Novartis Investigative Site, Abashiri
Novartis Investigative Site, Fukagawa
Novartis Investigative Site, Hakodate
Novartis Investigative Site, Ishikari
Novartis Investigative Site, Iwamizawa
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Akashi
Novartis Investigative Site, Awaji
Novartis Investigative Site, Himeji
Novartis Investigative Site, Himeji
Novartis Investigative Site, Kakogawa
Novartis Investigative Site, Kakogawa
Novartis Investigative Site, Kobe
Novartis Investigative Site, Kobe
Novartis Investigative Site, Kobe
Novartis Investigative Site, Nishinomiya
Novartis Investigative Site, Takarazuka
Novartis Investigative Site, Takarazuka
Novartis Investigative Site, Mito
Novartis Investigative Site, Mito
Novartis Investigative Site, Kanazawa
Novartis Investigative Site, Morioka
Novartis Investigative Site, Takamatsu
Novartis Investigative Site, Fujisawa
Novartis Investigative Site, Kamakura
Novartis Investigative Site, Sagamihara
Novartis Investigative Site, Yokohama
Novartis Investigative Site, Mukou-City
Novartis Investigative Site, Iga
Novartis Investigative Site, Tamaru
Novartis Investigative Site, Tsu
Novartis Investigative Site, Tsu
Novartis Investigative Site, Higashimatsushima
Novartis Investigative Site, Shiogama
Novartis Investigative Site, Saito
Novartis Investigative Site, Iki
Novartis Investigative Site, Sasebo
Novartis Investigative Site, Kita-Katsuragi-gun
Novartis Investigative Site, Kurashiki
Novartis Investigative Site, Kurashiki
Novartis Investigative Site, Urasoe
Novartis Investigative Site, Sakai
Novartis Investigative Site, Kishima-gun
Novartis Investigative Site, Ureshino
Novartis Investigative Site, Kawaguchi
Novartis Investigative Site, Kawaguchi
Novartis Investigative Site, Sayama
Novartis Investigative Site, Toda
Novartis Investigative Site, Tokorozawa
Novartis Investigative Site, Tokorozawa
Novartis Investigative Site, Higashiohmi
Novartis Investigative Site, Gotemba
Novartis Investigative Site, Hamamatsu
Novartis Investigative Site, Sunto-gun
Novartis Investigative Site, Nasushiobara
Novartis Investigative Site, Utsunomiya
Novartis Investigative Site, Adachi City
Novartis Investigative Site, Adachi City
Novartis Investigative Site, Akiruno
Novartis Investigative Site, Hachiōji
Novartis Investigative Site, Hachiōji
Novartis Investigative Site, Katsushika-ku
Novartis Investigative Site, Machida
Novartis Investigative Site, Machida
Novartis Investigative Site, Machida
Novartis Investigative Site, Minato
Novartis Investigative Site, Minato-ku
Novartis Investigative Site, Nakano City
Novartis Investigative Site, Ōta-ku
Novartis Investigative Site, Ōta-ku
Novartis Investigative Site, Toshima City
Novartis Investigative Site, Takaoka
Novartis Investigative Site, Sakata
Novartis Investigative Site, Shinjō
Novartis Investigative Site, Shimonoseki
Novartis Investigative Site, Gifu
Novartis Investigative Site, Hiroshima
Novartis Investigative Site, Hiroshima
Novartis Investigative Site, Hiroshima
Novartis Investigative Site, Kumamoto
Novartis Investigative Site, Kumamoto
Novartis Investigative Site, Kumamoto
Novartis Investigative Site, Kyoto
Novartis Investigative Site, Nagasaki
Novartis Investigative Site, Osaka
Novartis Investigative Site, Osaka
Novartis Investigative Site, Osaka
Novartis Investigative Site, Osaka
Novartis Investigative Site, Ōita
Novartis Investigative Site, Ōita
Novartis Investigative Site, Saitama
Novartis Investigative Site, Shizuoka
Novartis Investigative Site, Tokushima
Novartis Investigative Site, Toyama
Novartis Investigative Site, Wakayama
Novartis Investigative Site, Yamaguchi
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY